Rigel Pharmaceuticals RIGL Deferred Tax Liabilities
Deferred Tax Liabilities at other companies
Other financials
Where this comes from
Reported directly by Rigel Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxLiabilitiesOther.
The official record: Rigel Pharmaceuticals’s 10-K, filed March 3, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rigel Pharmaceuticals's deferred tax liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rigel Pharmaceuticals's deferred tax liabilities?
- Rigel Pharmaceuticals (RIGL) reported deferred tax liabilities of $327K in Q4 2025.
- What does deferred tax liabilities mean?
- Future tax obligations from temporary differences — most commonly accelerated tax depreciation that creates higher current tax deductions than book depreciation.